Literature DB >> 26794691

Phospholipase A2-Induced Remodeling Processes on Liquid-Ordered/Liquid-Disordered Membranes Containing Docosahexaenoic or Oleic Acid: A Comparison Study.

Rayna Georgieva1, Kristina Mircheva2, Victoria Vitkova3, Konstantin Balashev2, Tzvetanka Ivanova2, Cedric Tessier4,5, Kamen Koumanov1, Philippe Nuss4,5, Albena Momchilova1, Galya Staneva1.   

Abstract

Vesicle cycling, which is an important biological event, involves the interplay between membrane lipids and proteins, among which the enzyme phospholipase A2 (PLA2) plays a critical role. The capacity of PLA2 to trigger the budding and fission of liquid-ordered (L(o)) domains has been examined in palmitoyl-docosahexaenoylphosphatidylcholine (PDPC) and palmitoyl-oleoylphosphatidylcholine (POPC)/sphingomyelin/cholesterol membranes. They both exhibited a L(o)/liquid-disordered (L(d)) phase separation. We demonstrated that PLA2 was able to trigger budding in PDPC-containing vesicles but not POPC ones. The enzymatic activity, line tension, and elasticity of the membrane surrounding the L(o) domains are critical for budding. The higher line tension of Lo domains in PDPC mixtures was assigned to the greater difference in order parameters of the coexisting phases. The higher amount of lysophosphatidylcholine generated by PLA2 in the PDPC-containing mixtures led to a less-rigid membrane, compared to POPC. The more elastic L(d) membranes in PDPC mixtures exert a lower counteracting force against the L(o) domain bending.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26794691     DOI: 10.1021/acs.langmuir.5b03317

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  7 in total

1.  Myconoside interacts with the plasma membranes and the actin cytoskeleton and provokes cytotoxicity in human lung adenocarcinoma A549 cells.

Authors:  Aneliya Kostadinova; Rusina Hazarosova; Tanya Topouzova-Hristova; Daniela Moyankova; Vesela Yordanova; Ralitsa Veleva; Biliana Nikolova; Albena Momchilova; Dimitar Djilianov; Galya Staneva
Journal:  J Bioenerg Biomembr       Date:  2022-01-06       Impact factor: 2.945

2.  Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations.

Authors:  C Tessier; K Sweers; A Frajerman; H Bergaoui; F Ferreri; C Delva; N Lapidus; A Lamaziere; J P Roiser; M De Hert; P Nuss
Journal:  Transl Psychiatry       Date:  2016-10-04       Impact factor: 6.222

3.  EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol.

Authors:  Miranda L Jacobs; Hammad A Faizi; Justin A Peruzzi; Petia M Vlahovska; Neha P Kamat
Journal:  Biophys J       Date:  2021-04-19       Impact factor: 3.699

4.  Effects of Dietary n-3 LCPUFA Supplementation on the Hippocampus of Aging Female Mice: Impact on Memory, Lipid Raft-Associated Glutamatergic Receptors and Neuroinflammation.

Authors:  Lucas Taoro-González; Daniel Pereda; Catalina Valdés-Baizabal; Miriam González-Gómez; José A Pérez; Fátima Mesa-Herrera; Ana Canerina-Amaro; Herminia Pérez-González; Covadonga Rodríguez; Mario Díaz; Raquel Marin
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 5.  Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

Authors:  Ariel Frajerman; Linda Scoriels; Oussama Kebir; Boris Chaumette
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

6.  Facile Mixing of Phospholipids Promotes Self-Assembly of Low-Molecular-Weight Biodegradable Block Co-Polymers into Functional Vesicular Architectures.

Authors:  Amit Kumar Khan; James C S Ho; Susmita Roy; Bo Liedberg; Madhavan Nallani
Journal:  Polymers (Basel)       Date:  2020-04-22       Impact factor: 4.329

7.  Omega-3 polyunsaturated fatty acids do not fluidify bilayers in the liquid-crystalline state.

Authors:  Augusta De Santis; Yaiza Varela; Jesús Sot; Gerardino D'Errico; Félix M Goñi; Alicia Alonso
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.